ErbB inhibitors ameliorate behavioral impairments of an animal model for schizophrenia: implication of their dopamine-modulatory actionsMakoto Mizuno, Hiroyuki Nawa|Translational Psychiatry|2013Cited by 28
Antipsychotic Potential of Quinazoline ErbB1 Inhibitors in a Schizophrenia Model Established With Neonatal Hippocampal LesioningMakoto Mizuno, Hiroyuki Nawa|Journal of Pharmacological Sciences|2010Cited by 18